首页> 外文期刊>Journal of Extracellular Vesicles >miRNA profiling of circulating EpCAM + extracellular vesicles: promising biomarkers of colorectal cancer
【24h】

miRNA profiling of circulating EpCAM + extracellular vesicles: promising biomarkers of colorectal cancer

机译:循环的EpCAM + 细胞外小泡的miRNA分析:大肠癌的有前途的生物标志物

获取原文
           

摘要

Cancer cells secrete small membranous extracellular vesicles (EVs) into their microenvironment and circulation. These contain biomolecules, including proteins and microRNAs (miRNAs). Both circulating EVs and miRNAs have received much attention as biomarker candidates for non-invasive diagnostics. Here we describe a sensitive analytical method for isolation and subsequent miRNA profiling of epithelial-derived EVs from blood samples of patients with colorectal cancer (CRC). The epithelial-derived EVs were isolated by immunoaffinity-capture using the epithelial cell adhesion molecule (EpCAM) as marker. This approach mitigates some of the specificity issues observed in earlier studies of circulating miRNAs, in particular the negative influence of miRNAs released by erythrocytes, platelets and non-epithelial cells. By applying this method to 2 small-scale patient cohorts, we showed that blood plasma isolated from CRC patients prior to surgery contained elevated levels of 13 EpCAM~(+)-EV miRNAs compared with healthy individuals. Upon surgical tumour removal, the plasma levels of 8 of these were reduced (miR-16-5p, miR-23a-3p, miR-23b-3p, miR-27a-3p, miR-27b-3p, miR-30b-5p, miR-30c-5p and miR-222-3p). These findings indicate that the miRNAs are of tumour origin and may have potential as non-invasive biomarkers for detection of CRC. This work describes a non-invasive blood-based method for sensitive detection of cancer with potential for clinical use in relation to diagnosis and screening. We used the method to study CRC; however, it is not restricted to this disease. It may in principle be used to study any cancer that release epithelial-derived EVs into circulation.
机译:癌细胞在其微环境和循环系统中分泌小的膜状细胞外囊泡(EV)。它们包含生物分子,包括蛋白质和microRNA(miRNA)。作为非侵入性诊断的生物标志物候选物,循环电动汽车和miRNA都受到了广泛关注。在这里,我们描述了一种敏感的分析方法,用于从结肠直肠癌(CRC)患者的血液样本中分离上皮来源的EV并进行随后的miRNA分析。使用上皮细胞粘附分子(EpCAM)作为标记,通过免疫亲和捕获分离上皮来源的EV。这种方法减轻了循环miRNA早期研究中观察到的某些特异性问题,特别是红细胞,血小板和非上皮细胞释放的miRNA的负面影响。通过将该方法应用于2个小规模患者队列,我们​​显示,与健康个体相比,在手术前从CRC患者中分离出的血浆中含有13种EpCAM〜(+)-EV miRNA升高的水平。手术切除肿瘤后,血浆中的8种降低(miR-16-5p,miR-23a-3p,miR-23b-3p,miR-27a-3p,miR-27b-3p,miR-30b-5p ,miR-30c-5p和miR-222-3p)。这些发现表明,miRNA是肿瘤起源的,可能具有作为检测CRC的非侵入性生物标志物的潜力。这项工作描述了一种非侵入性的基于血液的方法,用于敏感地检测癌症,具有与诊断和筛查相关的临床应用潜力。我们用这种方法研究CRC。然而,它不仅限于这种疾病。原则上,它可用于研究任何将上皮来源的EV释放到血液中的癌症。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号